The global chemoinformatics market size reached US$ 6.3 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 12.7 Billion by 2032, exhibiting a growth rate (CAGR) of 8.1% during 2023-2032.
Chemoinformatics is a new field of information technology (IT) that focuses on the collection, storage, analysis, and manipulation of chemical data. The chemical data includes small molecule formulas, structures, properties, spectra, and biological and industrial activities. Chemoinformatics helps define archival data protocols and represent three-dimensional (3D) molecular structures, which further enables searching and comparing of compounds with specific features. As a result, it is widely used in the pharmaceutical industry to discover and develop novel biotechnological processes and products.
Due to the massive amount of data generated while synthesizing new drugs, the leading market players are integrating advanced information storage and retrieval technologies in chemoinformatics. This helps researchers in efficiently storing information about the physical properties, 3D molecular and crystal structures, spectroscopic signatures, chemical reaction pathways, molecular functional groups and docking sites, and other parameters. These innovations are anticipated to propel the market growth.
Chemoinformatics is a new field of information technology (IT) that focuses on the collection, storage, analysis, and manipulation of chemical data. The chemical data includes small molecule formulas, structures, properties, spectra, and biological and industrial activities. Chemoinformatics helps define archival data protocols and represent three-dimensional (3D) molecular structures, which further enables searching and comparing of compounds with specific features. As a result, it is widely used in the pharmaceutical industry to discover and develop novel biotechnological processes and products.
Chemoinformatics Market Trends:
At present, the outbreak of coronavirus disease (COVID-19) represents one of the major factors positively influencing the utilization of chemoinformatics in anti-viral research or discovery of therapeutics against the disease. Apart from this, the surging cases of chronic diseases and the consequent need for novel drugs are also influencing the market growth. The increasing investments in research and development (R&D) projects are also catalyzing the demand for chemoinformatics to validate potential drug candidates and the effective management of data generated during molecular and atomic reactions. Moreover, the increasing awareness about personalized medicine is driving the market growth.Due to the massive amount of data generated while synthesizing new drugs, the leading market players are integrating advanced information storage and retrieval technologies in chemoinformatics. This helps researchers in efficiently storing information about the physical properties, 3D molecular and crystal structures, spectroscopic signatures, chemical reaction pathways, molecular functional groups and docking sites, and other parameters. These innovations are anticipated to propel the market growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global chemoinformatics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on application.Breakup by Application:
- Chemical Analysis
- Drug Discovery
- Drug Validation
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSolveIT GmbH, BIOVIA (Dassault Systèmes), ChemAxon, Inc., Eurofins CEREP SA (Eurofins Panlabs Inc.), Jubilant Biosys Inc., Molecular Discovery Ltd., OpenEye Scientific Software Inc. and Schrödinger Inc.Key Questions Answered in This Report:
- How has the global chemoinformatics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global chemoinformatics market?
- What are the key regional markets?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global chemoinformatics market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary9 Value Chain Analysis11 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Chemoinformatics Market
6 Market Breakup by Application
7 Market Breakup by Region
8 SWOT Analysis
10 Porters Five Forces Analysis
12 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- BioSolveIT GmbH
- BIOVIA (Dassault Systèmes)
- ChemAxon Inc.
- Eurofins CEREP SA (Eurofins Panlabs Inc.)
- Jubilant Biosys Inc.
- Molecular Discovery Ltd.
- OpenEye Scientific Software Inc.
- Schrödinger Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 6.3 Billion |
| Forecasted Market Value ( USD | $ 12.7 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
